查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2068635

智慧診斷設備市場預測至2034年－按產品類型、技術、連接方式、通路、應用、最終用戶和地區分類的全球分析

Smart Diagnostic Devices Market Forecasts to 2034 - Global Analysis By Product Type, Technology, Connectivity, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球智慧診斷設備市場規模將達到 284 億美元，到 2034 年將達到 726 億美元，預測期內複合年成長率為 12.4%。

智慧診斷設備是整合了先進感測技術、無線連接和人工智慧分析功能的智慧醫療設備，可在臨床和家庭環境中對健康狀況進行即時、連續或按需監測和診斷。這些設備包括穿戴式感測器、攜帶式照護現場檢測分析儀、植入式監視器和連網成像工具，它們可以將生理數據傳輸到雲端平台和臨床決策支援系統。

慢性病負擔日益加重，對持續遠端監測的需求不斷成長。

隨著糖尿病、心血管疾病和呼吸系統疾病等慢性病在全球範圍內的日益普遍，人們對超越常規體檢的持續診斷監測解決方案的需求也日益成長。能夠持續測量血糖值、心率、血氧飽和度和血壓的智慧診斷設備，可為臨床醫生提供時間序列資料流，從而實現更精準的治療決策和更早的健康狀況惡化檢測。將這些設備與人工智慧驅動的臨床平台整合，可以將原始感測器數據轉化為可操作的洞察，支持預防性護理干預措施，從而減少住院次數，並提高複雜慢性病患者的生活品質。

新醫療器材類別的法規核准流程複雜且報銷存在不確定性。

智慧診斷設備製造商必須應對複雜且不斷變化的監管路徑，這些路徑在不同市場之間存在顯著差異。在美國，FDA 對人工智慧驅動的診斷設備採用全新產品 (de novo) 和 510(k) 核准流程，要求提供充分的臨床證據，以證明其分析有效性和臨床效用。醫療保險和醫療補助服務中心 (CMS) 以及私人保險公司對新型設備類別的保險覆蓋通常落後於法規核准數年，這限制了即使是臨床有效的產品的商業性可行性。這些監管和保險覆蓋方面的不確定性增加了設備開發的財務風險，並減緩了創新智慧診斷技術在臨床實踐中廣泛應用的速度。

多參數穿戴式平台的擴展和數位生物標記的開發

能夠同時監測多種生理訊號（包括心臟、代謝、神經和呼吸系統生物標記）的新一代多參數穿戴裝置的開發，為市場帶來了巨大的成長機會。這些平台可以創建全面的健康檔案，支援疾病的早期檢測和跨多個疾病領域的個人化介入策略。隨著穿戴式感測器數據衍生的數位生物標記在心房顫動、睡眠呼吸中止症和帕金森氏症等疾病診斷中的科學有效性日益得到認可，面向消費者的智慧診斷平台的臨床可信度也在不斷提高，其在正規醫療機構中的應用範圍也在不斷擴大。

人們擔心設備的準確性限制和責任問題可能會影響臨床應用。

智慧診斷設備的臨床應用受到測量精確度問題的限制，尤其是在臨床環境中使用的消費級穿戴式感測器。據報道，脈搏血氧計和連續血糖監測等常用測量指標的精確度會因膚色、體態和患者族群差異而有所不同。由於缺乏既定的精確度標準或獨立的檢驗研究，臨床醫生在依賴智慧型裝置測量結果做出關鍵診斷決策時仍然持謹慎態度。此外，如果醫療服務提供者建議或使用測量結果不準確的智慧診斷工具，則可能面臨法律責任，這也是限制其在緊急臨床環境中應用的因素。

新型冠狀病毒（COVID-19）的影響：

新冠疫情顯著加速了智慧診斷設備市場的發展，遠端患者監護變得普遍，並對能夠追蹤新冠症狀和併發症的居家診斷工具產生了迫切需求。消費者對穿戴式脈搏血氧飽和度分析儀、非接觸式體溫計和家用血壓計的接受度大幅提升。醫療系統迅速實施了利用智慧診斷設備進行遠端患者監護的項目，以便在確保醫院容量的同時，更好地管理居家復健的新冠患者。這些由疫情引發的行為和製度變革，使消費者和臨床醫生對智慧診斷技術的興趣持續高漲，並在後疫情時代形成了永續的需求基礎。

在預測期內，穿戴式診斷設備細分市場預計將佔據最大的市場佔有率。

在消費者對持續健康監測的需求以及穿戴式裝置所獲得的生物標記臨床有效性不斷提高的推動下，穿戴式診斷設備領域預計將在預測期內佔據最大的市場佔有率。透過將先進的生物感測器整合到智慧型手錶、黏性貼片和智慧服裝等外形規格中，可以在不干擾日常生活的情況下，持續監測心率節律、活動水平、睡眠模式、代謝指標等。

預計人工智慧（AI）領域在預測期內將呈現最高的複合年成長率。

在預測期內，人工智慧 (AI) 領域預計將呈現最高的成長率，這反映了機器學習演算法對設備診斷準確性、預測能力和臨床效用的變革性影響。設備內建的 AI 處理功能無需依賴雲端連接，即可即時分析感測器數據並檢測異常模式，例如心律不整和低血糖發作。此外，AI 系統的持續學習能力意味著，隨著演算法利用聚合的真實世界數據不斷改進，設備效能會隨時間推移而提升，從而在設備的整個生命週期中逐步提高診斷準確性。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率。這主要得益於消費者醫療保健技術的高滲透率、蓬勃發展的數位健康新創企業生態系統，以及美國食品藥品監督管理局（FDA）的進步監管流程，該流程已促成眾多人工智慧智慧診斷設備的獲批。在美國，強大的私人保險和個人健康監測設備的自付費用，以及在心臟病、糖尿病和術後患者臨床計畫中不斷推廣的遠端持續監測，都進一步推動了這一成長。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於消費者健康意識的提高、智慧型手機普及推動連線健診設備的快速成長，以及中國、印度和東南亞地區慢性病管理項目的擴展。該地區糖尿病和高血壓患者群體龐大，因此對智慧動態血糖監測（CGM）和血壓監測解決方案的需求顯著成長。區域技術製造商正在開發針對亞太地區價格區間最佳化的智慧診斷設備，從而拓展市場進入。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球智慧診斷設備市場：依產品類型分類

  • 穿戴式診斷設備
  • 攜帶式診斷設備
  • 即時診斷設備
  • 植入式診斷設備
  • 其他產品類型

第6章 全球智慧診斷設備市場：依技術分類

  • 人工智慧（AI）
  • 物聯網 (IoT)
  • 機器學習（ML）
  • 生物感測器技術
  • 雲端運算
  • 巨量資料分析
  • 無線連接技術

第7章 全球智慧診斷市場：連結性

  • 支援藍牙的設備
  • 支援 Wi-Fi 的設備
  • 蜂窩網路連接設備
  • 支援NFC功能的設備
  • 雲端連線裝置

第8章 全球智慧診斷設備市場：按分銷管道分類

  • 線上銷售
  • 零售藥房
  • 醫院藥房
  • 直銷
  • 醫療設備銷售代理

第9章 全球智慧診斷設備市場：按應用分類

  • 循環系統診斷
  • 糖尿病監測
  • 呼吸系統診斷
  • 神經學診斷
  • 腫瘤診斷
  • 感染疾病檢測
  • 女性健康檢查
  • 健身和健康監測

第10章 全球智慧診斷設備市場：以最終用戶分類

  • 醫院和診所
  • 診斷檢查室
  • 居家照護環境
  • 門診手術中心
  • 研究和學術機構
  • 運動健身中心

第11章 全球智慧診斷設備市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Abbott Laboratories
  • Medtronic plc
  • Koninklijke Philips NV
  • GE HealthCare Technologies Inc.
  • Siemens Healthineers AG
  • F. Hoffmann-La Roche Ltd.
  • DexCom, Inc.
  • Boston Scientific Corporation
  • OMRON Corporation
  • Masimo Corporation
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • ResMed Inc.
  • AliveCor, Inc.
  • Baxter International Inc.
Product Code: SMRC37063

According to Stratistics MRC, the Global Smart Diagnostic Devices Market is accounted for $28.4 billion in 2026 and is expected to reach $72.6 billion by 2034, growing at a CAGR of 12.4% during the forecast period. Smart diagnostic devices are intelligent medical instruments embedded with advanced sensing technologies, wireless connectivity, and AI-powered analytics to enable real-time, continuous, or on-demand monitoring and diagnosis of health conditions across clinical and home settings. These devices span wearable sensors, portable point-of-care analyzers, implantable monitors, and connected imaging tools that transmit physiological data to cloud platforms and clinical decision support systems.

Market Dynamics:

Driver:

Rising chronic disease burden and expanding demand for continuous remote monitoring

The global prevalence of chronic conditions including diabetes, cardiovascular disease, and respiratory disorders is generating escalating demand for continuous diagnostic monitoring solutions that extend beyond periodic clinical encounters. Smart diagnostic devices capable of continuously measuring glycemic levels, cardiac rhythms, oxygen saturation, and blood pressure provide clinicians with longitudinal data streams that enable more informed treatment decisions and earlier detection of deterioration. The integration of these devices with AI-powered clinical platforms transforms raw sensor data into actionable insights, supporting proactive care interventions that reduce hospitalizations and improve quality of life for patients managing complex chronic conditions.

Restraint:

Regulatory clearance complexity and reimbursement uncertainty for novel device categories

Manufacturers of smart diagnostic devices must navigate complex and evolving regulatory pathways that vary significantly across major markets. In the United States, the FDA's de novo and 510(k) pathways for AI-enabled diagnostic devices require substantial clinical evidence demonstrating analytical validity and clinical utility. Reimbursement coverage for novel device categories by CMS and private payers often lags regulatory clearance by years, limiting commercial viability even for clinically effective products. This regulatory and reimbursement uncertainty increases the financial risk of device development and constrains the pace at which innovative smart diagnostic technologies reach widespread clinical adoption.

Opportunity:

Expansion of multiparameter wearable platforms and digital biomarker development

The development of next-generation multiparameter wearable devices capable of simultaneously monitoring multiple physiological signals including cardiac, metabolic, neurological, and respiratory biomarkers represents a substantial market growth opportunity. These platforms can generate comprehensive health profiles that support earlier disease detection and personalized intervention strategies across multiple condition areas. The growing scientific validation of digital biomarkers derived from wearable sensor data for conditions including atrial fibrillation, sleep apnea, and Parkinson's disease is expanding the clinical credibility of consumer-grade smart diagnostic platforms, broadening their applicability in formal healthcare settings.

Threat:

Device accuracy limitations and liability concerns impacting clinical adoption

The clinical adoption of smart diagnostic devices is tempered by concerns about measurement accuracy, particularly for consumer-grade wearable sensors applied in clinical contexts. Variations in sensor accuracy across different skin tones, body positions, and patient populations have been documented for commonly used metrics including pulse oximetry and continuous glucose monitoring. Clinicians remain cautious about relying on smart device readings for critical diagnostic decisions without established accuracy benchmarks and independent validation studies. Liability exposure for healthcare providers recommending or prescribing smart diagnostic tools that deliver inaccurate readings is an additional factor constraining adoption in high-acuity clinical settings.

Covid-19 Impact:

The COVID-19 pandemic substantially accelerated the smart diagnostic device market by normalizing remote patient monitoring and creating urgent demand for home-based diagnostic tools capable of tracking COVID-19 symptoms and complications. Consumer adoption of wearable pulse oximeters, contactless thermometers, and home blood pressure monitors surged dramatically. Healthcare systems rapidly deployed remote patient monitoring programs equipped with smart diagnostic devices to manage COVID-19 patients recovering at home while conserving hospital capacity. These pandemic-driven behavioral and institutional changes have sustained elevated consumer and clinical interest in smart diagnostic technology, providing a durable post-pandemic demand baseline.

The Wearable diagnostic devices segment is expected to be the largest during the forecast period

The Wearable diagnostic devices segment is expected to account for the largest market share during the forecast period, propelled by consumer demand for continuous health monitoring and the expanding clinical validation of wearable-derived biomarkers. The integration of advanced biosensors into form factors including smartwatches, adhesive patches, and smart clothing enables unobtrusive continuous monitoring of cardiac rhythm, activity levels, sleep patterns, and metabolic markers.

The Artificial Intelligence (AI) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Artificial Intelligence (AI) segment is predicted to witness the highest growth rate, , reflecting the transformative impact of machine learning algorithms on device diagnostic accuracy, predictive capability, and clinical utility. On-device AI processing enables real-time analysis of sensor data to detect abnormal patterns including irregular cardiac rhythms and hypoglycemic episodes without dependence on cloud connectivity. The continuous learning capabilities of AI systems also enable device performance to improve over time as algorithms are refined with aggregated real-world data, delivering progressively enhanced diagnostic accuracy throughout the device lifecycle.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, underpinned by high consumer health technology adoption, a robust digital health startup ecosystem, and progressive FDA regulatory pathways that have cleared numerous AI-enabled smart diagnostic devices. The United States benefits from strong private insurance and out-of-pocket spending on personal health monitoring devices, combined with growing clinical program adoption of continuous remote monitoring across cardiac, diabetic, and post-surgical patient populations.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by surging consumer health awareness, rapid adoption of connected health devices enabled by widespread smartphone penetration, and expanding chronic disease management programs in China, India, and Southeast Asia. The region's large diabetic and hypertensive populations create substantial demand for smart CGM and blood pressure monitoring solutions. Regional technology manufacturers are developing cost-optimized smart diagnostic devices tailored to Asia Pacific price points, broadening market accessibility to middle-income consumer segments.

Key players in the market

Some of the key players in Smart Diagnostic Devices Market include Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., DexCom, Inc., Boston Scientific Corporation, OMRON Corporation, Masimo Corporation, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, ResMed Inc., AliveCor, Inc., and Baxter International Inc.

Key Developments:

In February 2026, AliveCor, Inc. received expanded FDA clearance for its KardiaMobile cardiac monitoring platform, enabling clinicians to prescribe the device for continuous at-home cardiac rhythm surveillance in patients recovering from cardiac procedures and those at elevated risk of atrial fibrillation recurrence.

In January 2026, Abbott Laboratories announced the commercial launch of its next-generation continuous glucose monitoring system featuring enhanced AI-driven predictive glucose alerting capabilities, providing diabetic patients with advance warning of hypoglycemic events up to 60 minutes before occurrence.

Product Types Covered:

  • Wearable Diagnostic Devices
  • Portable Diagnostic Devices
  • Point-of-Care Diagnostic Devices
  • Implantable Diagnostic Devices
  • Other Product Types

Technologies Covered:

  • Artificial Intelligence (AI)
  • Internet of Things (IoT)
  • Machine Learning (ML)
  • Biosensor Technology
  • Cloud Computing
  • Big Data Analytics
  • Wireless Connectivity Technologies

Connectivities Covered:

  • Bluetooth-Enabled Devices
  • Wi-Fi Enabled Devices
  • Cellular Connected Devices
  • NFC-Enabled Devices
  • Cloud-Integrated Devices

Distribution Channels Covered:

  • Online Sales
  • Retail Pharmacies
  • Hospital Pharmacies
  • Direct Sales
  • Medical Device Distributors

Applications Covered:

  • Cardiology Diagnostics
  • Diabetes Monitoring
  • Respiratory Diagnostics
  • Neurology Diagnostics
  • Oncology Diagnostics
  • Infectious Disease Detection
  • Women's Health Diagnostics
  • Fitness and Wellness Monitoring

End Users Covered:

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Homecare Settings
  • Ambulatory Surgical Centers
  • Research and Academic Institutes
  • Sports and Fitness Centers

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
      • Saudi Arabia
      • United Arab Emirates
      • Qatar
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Egypt
      • Morocco
      • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Smart Diagnostic Devices Market, By Product Type

  • 5.1 Wearable Diagnostic Devices
  • 5.2 Portable Diagnostic Devices
  • 5.3 Point-of-Care Diagnostic Devices
  • 5.4 Implantable Diagnostic Devices
  • 5.5 Other Product Types

6 Global Smart Diagnostic Devices Market, By Technology

  • 6.1 Artificial Intelligence (AI)
  • 6.2 Internet of Things (IoT)
  • 6.3 Machine Learning (ML)
  • 6.4 Biosensor Technology
  • 6.5 Cloud Computing
  • 6.6 Big Data Analytics
  • 6.7 Wireless Connectivity Technologies

7 Global Smart Diagnostic Devices Market, By Connectivity

  • 7.1 Bluetooth-Enabled Devices
  • 7.2 Wi-Fi Enabled Devices
  • 7.3 Cellular Connected Devices
  • 7.4 NFC-Enabled Devices
  • 7.5 Cloud-Integrated Devices

8 Global Smart Diagnostic Devices Market, By Distribution Channel

  • 8.1 Online Sales
  • 8.2 Retail Pharmacies
  • 8.3 Hospital Pharmacies
  • 8.4 Direct Sales
  • 8.5 Medical Device Distributors

9 Global Smart Diagnostic Devices Market, By Application

  • 9.1 Cardiology Diagnostics
  • 9.2 Diabetes Monitoring
  • 9.3 Respiratory Diagnostics
  • 9.4 Neurology Diagnostics
  • 9.5 Oncology Diagnostics
  • 9.6 Infectious Disease Detection
  • 9.7 Women's Health Diagnostics
  • 9.8 Fitness and Wellness Monitoring

10 Global Smart Diagnostic Devices Market, By End User

  • 10.1 Hospitals and Clinics
  • 10.2 Diagnostic Laboratories
  • 10.3 Homecare Settings
  • 10.4 Ambulatory Surgical Centers
  • 10.5 Research and Academic Institutes
  • 10.6 Sports and Fitness Centers

11 Global Smart Diagnostic Devices Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Abbott Laboratories
  • 14.2 Medtronic plc
  • 14.3 Koninklijke Philips N.V.
  • 14.4 GE HealthCare Technologies Inc.
  • 14.5 Siemens Healthineers AG
  • 14.6 F. Hoffmann-La Roche Ltd.
  • 14.7 DexCom, Inc.
  • 14.8 Boston Scientific Corporation
  • 14.9 OMRON Corporation
  • 14.10 Masimo Corporation
  • 14.11 Bio-Rad Laboratories, Inc.
  • 14.12 Becton, Dickinson and Company
  • 14.13 ResMed Inc.
  • 14.14 AliveCor, Inc.
  • 14.15 Baxter International Inc.

List of Tables

  • Table 1 Global Smart Diagnostic Devices Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Smart Diagnostic Devices Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Smart Diagnostic Devices Market Outlook, By Wearable Diagnostic Devices (2023-2034) ($MN)
  • Table 4 Global Smart Diagnostic Devices Market Outlook, By Portable Diagnostic Devices (2023-2034) ($MN)
  • Table 5 Global Smart Diagnostic Devices Market Outlook, By Point-of-Care Diagnostic Devices (2023-2034) ($MN)
  • Table 6 Global Smart Diagnostic Devices Market Outlook, By Implantable Diagnostic Devices (2023-2034) ($MN)
  • Table 7 Global Smart Diagnostic Devices Market Outlook, By Other Product Types (2023-2034) ($MN)
  • Table 8 Global Smart Diagnostic Devices Market Outlook, By Technology (2023-2034) ($MN)
  • Table 9 Global Smart Diagnostic Devices Market Outlook, By Artificial Intelligence (AI) (2023-2034) ($MN)
  • Table 10 Global Smart Diagnostic Devices Market Outlook, By Internet of Things (IoT) (2023-2034) ($MN)
  • Table 11 Global Smart Diagnostic Devices Market Outlook, By Machine Learning (ML) (2023-2034) ($MN)
  • Table 12 Global Smart Diagnostic Devices Market Outlook, By Biosensor Technology (2023-2034) ($MN)
  • Table 13 Global Smart Diagnostic Devices Market Outlook, By Cloud Computing (2023-2034) ($MN)
  • Table 14 Global Smart Diagnostic Devices Market Outlook, By Big Data Analytics (2023-2034) ($MN)
  • Table 15 Global Smart Diagnostic Devices Market Outlook, By Wireless Connectivity Technologies (2023-2034) ($MN)
  • Table 16 Global Smart Diagnostic Devices Market Outlook, By Connectivity (2023-2034) ($MN)
  • Table 17 Global Smart Diagnostic Devices Market Outlook, By Bluetooth-Enabled Devices (2023-2034) ($MN)
  • Table 18 Global Smart Diagnostic Devices Market Outlook, By Wi-Fi Enabled Devices (2023-2034) ($MN)
  • Table 19 Global Smart Diagnostic Devices Market Outlook, By Cellular Connected Devices (2023-2034) ($MN)
  • Table 20 Global Smart Diagnostic Devices Market Outlook, By NFC-Enabled Devices (2023-2034) ($MN)
  • Table 21 Global Smart Diagnostic Devices Market Outlook, By Cloud-Integrated Devices (2023-2034) ($MN)
  • Table 22 Global Smart Diagnostic Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 23 Global Smart Diagnostic Devices Market Outlook, By Online Sales (2023-2034) ($MN)
  • Table 24 Global Smart Diagnostic Devices Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 25 Global Smart Diagnostic Devices Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 26 Global Smart Diagnostic Devices Market Outlook, By Direct Sales (2023-2034) ($MN)
  • Table 27 Global Smart Diagnostic Devices Market Outlook, By Medical Device Distributors (2023-2034) ($MN)
  • Table 28 Global Smart Diagnostic Devices Market Outlook, By Application (2023-2034) ($MN)
  • Table 29 Global Smart Diagnostic Devices Market Outlook, By Cardiology Diagnostics (2023-2034) ($MN)
  • Table 30 Global Smart Diagnostic Devices Market Outlook, By Diabetes Monitoring (2023-2034) ($MN)
  • Table 31 Global Smart Diagnostic Devices Market Outlook, By Respiratory Diagnostics (2023-2034) ($MN)
  • Table 32 Global Smart Diagnostic Devices Market Outlook, By Neurology Diagnostics (2023-2034) ($MN)
  • Table 33 Global Smart Diagnostic Devices Market Outlook, By Oncology Diagnostics (2023-2034) ($MN)
  • Table 34 Global Smart Diagnostic Devices Market Outlook, By Infectious Disease Detection (2023-2034) ($MN)
  • Table 35 Global Smart Diagnostic Devices Market Outlook, By Women's Health Diagnostics (2023-2034) ($MN)
  • Table 36 Global Smart Diagnostic Devices Market Outlook, By Fitness and Wellness Monitoring (2023-2034) ($MN)
  • Table 37 Global Smart Diagnostic Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 38 Global Smart Diagnostic Devices Market Outlook, By Hospitals and Clinics (2023-2034) ($MN)
  • Table 39 Global Smart Diagnostic Devices Market Outlook, By Diagnostic Laboratories (2023-2034) ($MN)
  • Table 40 Global Smart Diagnostic Devices Market Outlook, By Homecare Settings (2023-2034) ($MN)
  • Table 41 Global Smart Diagnostic Devices Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 42 Global Smart Diagnostic Devices Market Outlook, By Research and Academic Institutes (2023-2034) ($MN)
  • Table 43 Global Smart Diagnostic Devices Market Outlook, By Sports and Fitness Centers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.